read somewhere that PIB isn't the greatest stuff to be breathing in. Couldn't remember where so i'm gogglin "Polyisobutylene health" ie. PIB (used in k2 & super m)
----------------------------------------------------------------------------
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&ved=0CCsQFjACahUKEwiaksjRluLGAhWCdD4KHX2vDhE&url=https://www.oronite.com/pdfs/polyisobutylene_productstewardshipsummary.pdf&ei=bfaoVdqnJYLp-QH93rqIAQ&usg=AFQjCNE1CayDHAmSz_PqDNQj8VUW1HzqSw&sig2=HsJMhBx8UOPO6B1Q37JwHg&cad=rja
page 3
health info
so it sounds like the best way to get systemic toxicity is to breathe in the fumes of products containing PIB based additives
----------------------------------------------------------------------------
See below... so looks like you are fcked but don't know it til 24-72hrs later LOL
PIB -
http://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1260
0.4.3 INHALATION EXPOSURE
A) DECONTAMINATION -
1) INHALATION: Move patient to fresh air. Monitor for
respiratory distress. If cough or difficulty breathing
develops, evaluate for respiratory tract irritation,
bronchitis, or pneumonitis. Administer oxygen and
assist ventilation as required. Treat bronchospasm with
an inhaled beta2-adrenergic agonist. Consider systemic
corticosteroids in patients with significant
bronchospasm.
B) IRRITATION -
1) Respiratory tract irritation, if severe,
can progress
to pulmonary edema which may be delayed in onset up to
24 to 72 hours after exposure in some cases.
C) ACUTE LUNG INJURY -
1) ACUTE LUNG INJURY: Maintain ventilation and oxygenation
and evaluate with frequent arterial blood gases and/or
pulse oximetry monitoring. Early use of PEEP and
mechanical ventilation may be needed.
D) BRONCHOSPASM -
1) If bronchospasm and wheezing occur, consider treatment
with inhaled sympathomimetic agents.
E) OBSERVATION CRITERIA -
1) Carefully observe patients with inhalation exposure for
the development of any systemic signs or symptoms and
administer symptomatic treatment as necessary.
2) Patients symptomatic following exposure should be
observed in a controlled setting until all signs and
symptoms have fully resolved.